---
title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293339388.md"
description: "In Tuesday's pre-market session, several healthcare stocks saw significant movement. Gainers included Jupiter Neurosciences (+36.4%), Imunon (+14.09%), and Akari Therapeutics (+10.69%). Conversely, Zhengye Biotechnology dropped sharply by 48.9%, followed by Lisata Therapeutics (-26.25%) and VYNE Therapeutics (-22.02%). The report highlights specific price changes and market capitalizations for these listed companies."
datetime: "2026-07-21T12:05:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293339388.md)
  - [en](https://longbridge.com/en/news/293339388.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293339388.md)
---

# 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

### Gainers

-   **Jupiter Neurosciences** (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.9 million.
-   **Imunon** (NASDAQ:IMNN) shares moved upwards by 14.09% to $2.02. The company's market cap stands at $7.4 million.
-   **Akari Therapeutics** (NASDAQ:AKTX) shares increased by 10.69% to $11.8. The market value of their outstanding shares is at $18.6 million.
-   **Prothena Corp** (NASDAQ:PRTA) shares increased by 9.57% to $9.5. The company's market cap stands at $453.9 million.
-   **Quantum BioPharma** (NASDAQ:QNTM) stock moved upwards by 7.56% to $3.27. The company's market cap stands at $19.4 million.
-   **Radiopharm Theranostics** (NASDAQ:RADX) stock moved upwards by 7.47% to $4.6. The market value of their outstanding shares is at $33.2 million.

### Losers

-   **Zhengye Biotechnology** (NASDAQ:ZYBT) shares declined by 48.9% to $4.09 during Tuesday's pre-market session. The company's market cap stands at $379.6 million.
-   **Lisata Therapeutics** (NASDAQ:LSTA) stock decreased by 26.25% to $2.6. The market value of their outstanding shares is at $32.1 million.
-   **VYNE Therapeutics** (NASDAQ:VYNE) shares decreased by 22.02% to $0.63. The market value of their outstanding shares is at $26.9 million.
-   **GlucoTrack** (NASDAQ:GCTK) shares declined by 15.31% to $0.35. The market value of their outstanding shares is at $2.6 million.
-   **Calidi Biotherapeutics** (AMEX:CLDI) stock fell 14.97% to $0.1. The company's market cap stands at $2.2 million.
-   **Catheter Precision** (AMEX:VTAK) shares decreased by 14.65% to $0.43. The company's market cap stands at $1.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [IMNN.US](https://longbridge.com/en/quote/IMNN.US.md)
- [JUNS.US](https://longbridge.com/en/quote/JUNS.US.md)
- [AKTX.US](https://longbridge.com/en/quote/AKTX.US.md)
- [LSTA.US](https://longbridge.com/en/quote/LSTA.US.md)
- [VYNE.US](https://longbridge.com/en/quote/VYNE.US.md)
- [YARW.US](https://longbridge.com/en/quote/YARW.US.md)
- [PRTA.US](https://longbridge.com/en/quote/PRTA.US.md)
- [QNTM.US](https://longbridge.com/en/quote/QNTM.US.md)
- [RADX.US](https://longbridge.com/en/quote/RADX.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [CLDI.US](https://longbridge.com/en/quote/CLDI.US.md)
- [VTAK.US](https://longbridge.com/en/quote/VTAK.US.md)

## Related News & Research

- [EXCLUSIVE: Imunon Outlines Accelerated Timeline, Strong Safety Data for Pivotal Ovarian Cancer Study](https://longbridge.com/en/news/294368697.md)
- [Imunon says Phase 3 OVATION 3 ovarian cancer trial enrollment outpaces plan](https://longbridge.com/en/news/294371031.md)
- [Healthcare of Ontario Pension Plan Trust Fund Increases Position in Webull Corporation $BULL](https://longbridge.com/en/news/294484857.md)
- [Vyne Therapeutics issues pre-funded warrants for 133,290 shares in stock exchange deal](https://longbridge.com/en/news/294409414.md)
- [GKV Capital Management Co. Inc. Takes Position in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/294577517.md)